These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12387283)

  • 21. Efficacy and safety of the long-term administration of low-molecular-weight heparins in pregnancy.
    Santoro R; Iannaccaro P; Prejanò S; Muleo G
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):240-3. PubMed ID: 19357505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation].
    Tebbe U
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2033-6. PubMed ID: 17882745
    [No Abstract]   [Full Text] [Related]  

  • 23. Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss.
    Ramidi G; Khan N; Glueck CJ; Wang P; Goldenberg N
    Transl Res; 2009 Jan; 153(1):33-43. PubMed ID: 19100956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel point-of-care assay for the monitoring of low-molecular weight heparins in the cardiac catheterization laboratory.
    Marmur JD; Lakhani M; El Rouby S; Cavusoglu E
    J Invasive Cardiol; 2008 Sep; 20(9):449-54. PubMed ID: 18762674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves. Review of international clinical guidelines].
    Adilova LR; Shifman EM; Adamian LV; Liashko ES; Tiul'kina EE
    Anesteziol Reanimatol; 2013; (6):62-6. PubMed ID: 24749270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analgesia for childbirth in a patient with factor V Leiden mutation].
    Puértolas Ortega M; Izquierdo Villarroya B; Oliva Perales P; Lafuente Ojeda N; Izquierdo Villarroya J; Ruiz Pérez R
    Rev Esp Anestesiol Reanim; 2007 Jan; 54(1):41-4. PubMed ID: 17319433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
    Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
    Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High factor XI, recurrent pregnancy loss, enoxaparin.
    Glueck CJ; Pranikoff J; Khan N; Riaz K; Chavan K; Raj P; Umar M; Wang P
    Fertil Steril; 2010 Dec; 94(7):2828-31. PubMed ID: 21094629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review.
    Duhl AJ
    J Reprod Med; 2008 Sep; 53(9):657-66. PubMed ID: 18839817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants.
    Grandone E; De Stefano V; Rossi E; Cappucci F; Colaizzo D; Margaglione M
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):226-30. PubMed ID: 18388503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of low molecular weight heparin in pregnant women with mechanical heart valves.
    Yinon Y; Siu SC; Warshafsky C; Maxwell C; McLeod A; Colman JM; Sermer M; Silversides CK
    Am J Cardiol; 2009 Nov; 104(9):1259-63. PubMed ID: 19840573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis.
    Fox NS; Laughon SK; Bender SD; Saltzman DH; Rebarber A
    Obstet Gynecol; 2008 Oct; 112(4):884-9. PubMed ID: 18827132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylaxis and treatment of thrombophilia in pregnancy.
    Gris JC; Lissalde-Lavigne G; Quéré I; Dauzat M; Marès P
    Curr Opin Hematol; 2006 Sep; 13(5):376-81. PubMed ID: 16888444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
    Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
    Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
    Ghosh K; Shetty S; Vora S; Salvi V
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical application of enoxaparin.
    Hofmann T
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):321-37. PubMed ID: 15151480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease.
    Kleber FX; Witt C; Vogel G; Koppenhagen K; Schomaker U; Flosbach CW;
    Am Heart J; 2003 Apr; 145(4):614-21. PubMed ID: 12679756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant.
    Michaels LA; Gurian M; Hegyi T; Drachtman RA
    Pediatrics; 2004 Sep; 114(3):703-7. PubMed ID: 15342842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Usefulness of a scoring system on perinatal outcomes in pregnant women with thrombophilia in the effectiveness of an enoxaparin-based intervention].
    Figueiró-Filho EA; de Oliveira VM; Breda I; Coelho LR; Ferreira CM
    Rev Bras Ginecol Obstet; 2012 Oct; 34(10):459-65. PubMed ID: 23288223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Bridging" therapy with low molecular weight heparin in pregnant patients and patients with mechanical prosthetic heart valves.
    Groce JB
    J Thromb Thrombolysis; 2003; 16(1-2):79-82. PubMed ID: 14760218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.